The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
about
Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology updateContinuous glucose monitoring: evidence and consensus statement for clinical useRecommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileAssessing sensor accuracy for non-adjunct use of continuous glucose monitoringRecommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesClinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.CGM, Pregnancy, and Remote MonitoringContinuous Glucose Monitoring and Global Reimbursement: An Update.The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristicsHome use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyImpact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH studySystematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoringThe impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trialLessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapyContinuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemiaClinical evaluation of the use of a multifunctional remotely controlled insulin pump: multicenter observational studyUnsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.Impact of new technologies on diabetes care.HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple DaHigh reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy.Analysis: The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System.Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies.Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitusImpact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One YearAre Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?The role of continuous glucose monitoring in the care of children with type 1 diabetes.Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference.Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.Continuous glucose monitoring pilot in low-income type 1 diabetes patients.Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetesDifferences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesInfluences on Technology Use and Efficacy in Type 1 DiabetesEffective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.Continuous glucose monitoring in 2013.
P2860
Q26785492-E859A195-85FF-4E9D-A867-9ECBA8508570Q27022628-CC52EF9E-0E6C-4D3A-A87E-B7F54DDF12AFQ27687563-ED6F600C-5552-4B30-B779-B060FE129A46Q30301250-B93BE757-3481-4F67-81AF-90C34198935EQ31121925-26942BBE-B55B-4A8C-B17E-3B436CA9C3B1Q33727481-D52663C5-E7F0-46C3-9EDA-5A96FE337AD2Q33786126-D0CF839E-7454-4C30-8A8B-7796E5FCB664Q33786148-6ACC28B6-A73D-4AA7-AD9B-410D355D9608Q33945186-0195EBB3-D058-4911-A30A-6E122B14471BQ34194737-8C46BE80-73FD-4FFC-8D23-D1D63E8EA6E6Q34252778-A7823754-26F1-4385-96C9-1482ED0CB514Q34856962-F724DCC6-05FE-4C82-993A-99444EC8C466Q35608590-4B0D6C96-FC31-4562-AEC3-937031C7B507Q35682794-D1884D68-D342-4007-B2A7-900390131921Q35682802-2677B71F-2DEE-4388-875A-F053DA8A7214Q35682809-9710FEF8-2CB7-460B-901A-D7773C2A0D52Q35682902-0BBA11D8-307E-4120-A26E-7426EEBEE4FDQ35877744-92F745FB-4DCC-4FD2-98D2-77CBA6453F9FQ35890221-068FD90D-19E3-4E88-898D-CC5412A61C41Q36159014-2FB94B84-D395-4505-8BA2-A0EF7FB4D422Q36159100-FD950382-CA70-4D8D-AE8E-8F704BB3DC62Q36340531-AFB08042-35DB-475F-9B03-C57F62C4308CQ36475919-483B6948-F719-4686-9891-F73922D75653Q36475961-0718D414-CE03-47E7-B355-BF982AD1DD25Q36554596-B946A70E-D4AA-404C-B1E9-B5442F4388F3Q36638881-5A7D80B6-C534-4D3F-97EC-0496A92B69B3Q36638904-9A95E902-EC9B-4E50-9508-578BE0002588Q36777662-7328DFA3-F69B-4420-8314-45AC73B027A2Q36968348-4A5A57FE-991C-4E13-8A3C-970042733B32Q37054661-3886C1D9-FBDE-40E7-B526-1F459D3B51E4Q37054720-326CBA61-4B7E-487E-84A9-CA27A2837F7BQ37192472-DA64944B-51B0-4B3D-B202-91E921C4B7B6Q37193478-4F533E0B-092F-4940-9E95-B07D0ECA2AA6Q37275395-B7C1D5AC-1E74-4F5C-AD7D-7D3C3A4AA99DQ37280510-CB5668AF-BB47-4823-B4CC-F74E292854F3Q37288543-22E4CB6F-6E67-411A-A783-55F63C2D53DFQ37288564-85E0EEA6-5773-4D3E-98A9-3F491E2281B3Q37433075-3DDA9C1C-3049-4671-B6F8-A35E285A9D06Q37492413-712EAACC-A676-4707-9204-88BD33113807Q37577292-C303ED49-1AB7-4295-8061-2BCF04499BE7
P2860
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The use and efficacy of contin ...... a randomised controlled trial.
@ast
The use and efficacy of contin ...... a randomised controlled trial.
@en
type
label
The use and efficacy of contin ...... a randomised controlled trial.
@ast
The use and efficacy of contin ...... a randomised controlled trial.
@en
prefLabel
The use and efficacy of contin ...... a randomised controlled trial.
@ast
The use and efficacy of contin ...... a randomised controlled trial.
@en
P2093
P2860
P921
P1433
P1476
The use and efficacy of contin ...... a randomised controlled trial.
@en
P2093
I Schütz-Fuhrmann
J Bolinder
SWITCH Study Group
U Schierloh
P2860
P2888
P304
P356
10.1007/S00125-012-2708-9
P577
2012-09-11T00:00:00Z